GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of KALV
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

KalVista Pharmaceuticals Inc stock price down 1.29% on Thursday
(Updated on Apr 18, 2024)

Sell candidate since Apr 17, 2024 Loss -1.29% PDF

The KalVista Pharmaceuticals Inc stock price fell by -1.29% on the last day (Thursday, 18th Apr 2024) from $11.65 to $11.50. During the last trading day the stock fluctuated 4.17% from a day low at $11.28 to a day high of $11.75. The price has fallen in 6 of the last 10 days but is still up by 2.59% over the past 2 weeks. Volume has increased on the last day by 110 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 398 thousand shares were bought and sold for approximately $4.58 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -21.15% during the next 3 months and, with a 90% probability hold a price between $8.16 and $10.55 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

KALV Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, April 02, 2024, and so far it has risen 4.17%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The KalVista Pharmaceuticals Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $11.81 and $12.22. A break-up above any of these levels will issue buy signals. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for KalVista Pharmaceuticals Inc stock

KalVista Pharmaceuticals Inc finds support from accumulated volume at $11.40 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.470 between high and low, or 4.17%. For the last week, the stock has had daily average volatility of 4.00%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (KALV) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect KalVista Pharmaceuticals Inc to open at $11.51, and during the day (based on 14 day Average True Range), to move between $10.88 and $12.12, which gives a possible trading interval of +/-$0.623 (+/-5.42%) up or down from last closing price. If KalVista Pharmaceuticals Inc takes out the full calculated possible swing range there will be an estimated 10.83% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $11.40 (0.87%) than the resistance at $11.86 (3.13%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is KalVista Pharmaceuticals Inc stock A Buy?

KalVista Pharmaceuticals Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.724 Sell Candidate Unchanged

Predicted Opening Price for KalVista Pharmaceuticals Inc of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$11.51 ( 0.0870%) $11.50

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for KALV

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 11.98 4.17 %
R2 11.80 2.61 %
R1 11.69 1.65 %
Current price: 11.50
Support S1 11.33 -1.47 %
S2 11.22 -2.44 %
S3 11.04 -4.00 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 13.80 20.00 %
R2 12.58 9.39 %
R1 11.86 3.13 %
Current price 11.50
Support S1 11.40 -0.87%
S2 11.11 -3.39%
S3 11.04 -4.00%

FAQ

What is the symbol for KalVista Pharmaceuticals Inc Stock and on which exchange is it traded?
The symbol for KalVista Pharmaceuticals Inc is KALV and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell KalVista Pharmaceuticals Inc Stock?
KalVista Pharmaceuticals Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy KalVista Pharmaceuticals Inc Stock?
KalVista Pharmaceuticals Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy KalVista Pharmaceuticals Inc Stock.

What's the current price of KalVista Pharmaceuticals Inc Stock?
As of the end of day on the 2024-04-18, the price of an KalVista Pharmaceuticals Inc (KALV) share was $11.50.

What is the 52-week high and low for KalVista Pharmaceuticals Inc Stock?
The 52-week high for KalVista Pharmaceuticals Inc Stock is $16.88 and the 52-week low is $7.21.

What is the market capitalization of KalVista Pharmaceuticals Inc Stock?
As of the 2024-04-18, the market capitalization of KalVista Pharmaceuticals Inc is 491.494M.

When is the next earnings date for KalVista Pharmaceuticals Inc?
The upcoming earnings date for KalVista Pharmaceuticals Inc is Jul 05, 2024.
Click to get the best stock tips daily for free!

About KalVista Pharmaceuticals Inc

KalVista Pharmaceuticals KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral plasma kallikrein inhibitors. Its products include KVD001, a plasma kallikrein inhibitor that completed ... KALV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT